Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia
The Journal of Clinical Psychiatry · 2024
DOI: 10.4088/jcp.23m15095 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift The Journal of Clinical Psychiatry, 2024. Verfasst von Leslie Citrome und 3 weiteren Autor:innen. Beteiligte Einrichtung: New York Medical College, Valhalla, New York. Hauptthemen laut MEDLINE: Antipsychotic Agents, Hypotension, Nanoparticles, Noncommunicable Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- New York Medical College, Valhalla, New York.
- Corresponding Author: Leslie Citrome, MD, MPH, New York Medical College, 40 Sunshine Cottage Rd, Valhalla, NY 10595 (nntman@gmail.com).
- Alkermes, Inc., Waltham, Massachusetts.
Zitieren
APA
Citrome, L., Yagoda, S., Bidollari, I., & Wang, M. (2024). Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.23m15095
Vancouver
Citrome L, Yagoda S, Bidollari I, Wang M. Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia. The Journal of Clinical Psychiatry. 2024. doi:10.4088/jcp.23m15095
BibTeX
@article{Citrome2024,
author = {Citrome, Leslie and Yagoda, Sergey and Bidollari, Ilda and Wang, Meihua},
title = {Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia},
journal = {The Journal of Clinical Psychiatry},
year = {2024},
doi = {10.4088/jcp.23m15095}
}
EUVIMED